Smith Daisy, Lovell Janaka, Weller Carolina, Kennedy Briohny, Winbolt Margaret, Young Carmel, Ibrahim Joseph
Department of Forensic Medicine, Monash University, Southbank, Victoria, Australia.
Ballarat Health Services, Ballarat, Victoria, Australia.
PLoS One. 2017 Feb 6;12(2):e0170651. doi: 10.1371/journal.pone.0170651. eCollection 2017.
Adherence to medication is vital for disease management while simultaneously reducing healthcare expenditure. Older persons with cognitive impairment (CI) are at risk for non-adherence as cognitive processes are needed to manage medications. This systematic review focuses on the relationship between medication non-adherence and specific cognitive domains in persons with CI, and explores determinants of medication non-adherence. When available, relationships and factors are compared with cognitively intact populations.
A seven database systematic search of studies published between 1 January 1949-31 December 2015 examining medication non-adherence in community dwelling persons with CI or dementia was conducted. Articles reporting medication non-adherence in people with CI or dementia in the community, with or without caregiver supports were eligible for inclusion. Papers reporting adherence to treatments in cognitively intact populations, populations from hospital or institutional settings, for non-prescribed medication or those describing dementia as a factor predicting medication non-adherence were excluded. Data on study and population characteristics, research design, data sources and analysis, specific cognitive domains, non-adherence prevalence, measurement of adherence, salient findings, factors associated with adherence and strategies to improve medication adherence were extracted. Study limitations included inconsistencies between data sources and definitions, resulting in a loss of fidelity in the value and comprehensiveness of data, as well as exclusion of non-pharmacological treatments and regimens.
Fifteen studies met inclusion criteria. Adherence among CI subjects ranged from 10.7%-38% with better rates of adherence in non-CI individuals. Medication non-adherence definitions varied considerably. New-learning, memory and executive functioning were associated with improved adherence and formed the focus of most studies. Multiple factors were identified as modulators of non-adherence.
This review highlights a gap in knowledge on how specific cognitive domains contribute to medication non-adherence amongst CI populations, and demonstrates the current focus is limited to two domains: memory and executive functioning.
坚持服药对于疾病管理至关重要,同时还能降低医疗支出。患有认知障碍(CI)的老年人存在不坚持服药的风险,因为管理药物需要认知过程。本系统评价聚焦于CI患者中药物不依从与特定认知领域之间的关系,并探讨药物不依从的决定因素。如有可能,将这些关系和因素与认知功能正常的人群进行比较。
对1949年1月1日至2015年12月31日期间发表的研究进行七数据库系统检索,这些研究考察了社区居住的CI或痴呆患者的药物不依从情况。报告社区中有无照料者支持的CI或痴呆患者药物不依从情况的文章符合纳入标准。排除报告认知功能正常人群、医院或机构环境中的人群、非处方药的治疗依从性,或描述痴呆为预测药物不依从因素的文章。提取有关研究和人群特征、研究设计、数据来源和分析、特定认知领域、不依从患病率、依从性测量、主要发现、与依从性相关的因素以及改善药物依从性策略的数据。研究局限性包括数据来源和定义之间的不一致,导致数据价值和全面性的准确性丧失,以及排除非药物治疗和方案。
15项研究符合纳入标准。CI受试者的依从率在10.7%至38%之间,非CI个体的依从率更高。药物不依从的定义差异很大。新学习、记忆和执行功能与依从性改善相关,并构成了大多数研究的重点。多个因素被确定为不依从的调节因素。
本综述凸显了关于特定认知领域如何导致CI人群药物不依从的知识空白,并表明目前的重点仅限于两个领域:记忆和执行功能。